Drapkin Kimberlee C is President, CFO and Treasurer of Jounce Therapeutics Inc.
Person profile
Roles
Address
Lexington, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
LENZ Therapeutics, Inc.
25 Mar 24
4
Graphite Bio, Inc.
1 Aug 23
3
Graphite Bio, Inc.
1 Aug 23
4
KINETA, INC./DE
5 Jul 23
3
KINETA, INC./DE
5 Jul 23
4
Acumen Pharmaceuticals, Inc.
7 Jun 23
4
Jounce Therapeutics, Inc.
4 May 23
4
Jounce Therapeutics, Inc.
11 Jan 23
144
Jounce Therapeutics, Inc.
6 Jan 23
4
Acumen Pharmaceuticals, Inc.
17 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Mar 24 | LENZ LENZ Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 15.05 | 27,000 | 406.35 k | 27,000 |
28 Jul 23 | LENZ LENZ Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.52 | 40,000 | 100.80 k | 40,000 |
6 Jun 23 | ABOS Acumen Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 5.2 | 25,000 | 130.00 k | 25,000 |
3 May 23 | JNCE Jounce Therapeutics | Common Stock | Dispose U | No | No | 0 | 40,267 | 0.00 | 0 | |
3 May 23 | JNCE Jounce Therapeutics | Common Stock | Dispose U | No | No | 0 | 25,751 | 0.00 | 40,267 | |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.56 | 55,000 | 415.80 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 11.89 | 44,500 | 529.11 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.55 | 53,400 | 349.77 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.4 | 44,500 | 195.80 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 23.98 | 97,500 | 2.34 mm | 0 |